In mammals, GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner, thus improving glucose homeostasis and ameliorating metabolic diseases, such as diabetes and obesity [12,13,14,15]. This evidence concerns the gene GCG and Other metabolic disease.